Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine

Go back to Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $4.35 
Open $0.38    52 Week Low $0.44 
Day High $0.38    P/E N/A 
Day Low $0.38    EPS $-0.81 
Volume 451